Symphogen Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IMNM | F | Immunome, Inc. | 3.59 | |
IVVD | F | Invivyd, Inc. | 0.00 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
DWAS | C | PowerShares DWA SmallCap Technical Leaders Portfolio | 0.79 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.65 | |
PTH | B | Invesco DWA Healthcare Momentum ETF | 0.56 | |
XBI | B | SPDR S&P Biotech ETF | 0.2 | |
LABU | C | Direxion Daily S&P Biotech Bull 3X Shares | 0.13 |
Compare ETFs
Related Industries:
Biotechnology
- Symphogen
Symphogen is a biotechnology company located in Copenhagen, Denmark that develops protein drugs based on recombinant monoclonal antibody mixtures. These drugs are different from the polyclonal antibodies, as each antibody in the mixture is produced from one carefully selected clone. Their three main areas of therapeutic research are immunoglobulin replacement, cancer, and infectious diseases. The company was founded in 2000 and has patents on a drug discovery platform called Symplex and a drug manufacturing platform called Sympress. By 2009, ten drugs were being developed with rozrolimupab (Sym001) being the lead product. Laboratoires Servier acquired Symphogen in 2020.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles